P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial (vol 7, e240877, 2024)

被引：1
|
作者：
Min, P. K.
Kang, T. S.
Cho, Y. H.
机构：
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2024.13426
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] P2Y12 Inhibitor-Based Single Antiplatelet Therapy Versus Conventional Dual Antiplatelet Therapy After Newer-Generation Drug-Eluting Stent Implantation in Chronic and Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Iglesias, Juan F.
    Assouline, Benjamin
    Chatelain, Quentin
    Musayeb, Yazan
    Degrauwe, Sophie
    Roffi, Marco
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (06):
  • [22] Impact of triple vs dual antiplatelet therapy on early clinical outcomes after drug-eluting stent implantation.
    Park, S. W.
    Park, D. W.
    Jeong, Y. H.
    Hwang, E. S.
    Lee, S. W.
    Kim, Y. H.
    Lee, B. K.
    Lee, C. W.
    Hong, M. K.
    Kim, J. J.
    Park, S. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8B): : 18D - 19D
  • [23] P2Y12 Inhibitor vs Aspirin Monotherapy Following Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: An Updated Meta-Analysis
    Gao, Tong
    Meng, Chang
    Wang, Yintang
    Li, Siyuan
    Bi, Lei
    Geng, Yu
    Zhang, Ping
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (10)
  • [24] P2Y12 INHIBITOR MONOTHERAPY AFTER A SHORT DUAL ANTIPLATELET THERAPY VS. 12-MONTH DUAL ANTIPLATELET THERAPY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS
    Ling, Hua
    Egolum, Ugochukwu
    Parker, Shanea
    Ho, Ai-Chen
    Dimmel, Jordan
    Hawkins, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 73 - 73
  • [25] Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
    Gérard Helft
    Claude Le Feuvre
    Jean Louis Georges
    Didier Carrie
    Florence Leclercq
    Hélène Eltchaninoff
    Alain Furber
    Fabrice Prunier
    Laurent Sebagh
    Simon Cattan
    Guillaume Cayla
    Eric Vicaut
    Jean-Philippe Metzger
    Trials, 14
  • [26] Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
    Helft, Gerard
    Le Feuvre, Claude
    Georges, Jean Louis
    Carrie, Didier
    Leclercq, Florence
    Eltchaninoff, Helene
    Furber, Alain
    Prunier, Fabrice
    Sebagh, Laurent
    Cattan, Simon
    Cayla, Guillaume
    Vicaut, Eric
    Metzger, Jean-Philippe
    TRIALS, 2013, 14
  • [27] Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial
    Gragnano, Felice
    Zwahlen, Marcel
    Vranckx, Pascal
    Heg, Dik
    Schmidlin, Kurt
    Hamm, Christian
    Steg, Philippe Gabriel
    Gargiulo, Giuseppe
    McFadden, Eugene P.
    Onuma, Yoshinobu
    Chichareon, Ply
    Benit, Edouard
    Mollmann, Helge
    Janssens, Luc
    Leonardi, Sergio
    Zurakowski, Aleksander
    Arrivi, Alessio
    van Geuns, Robert Jan
    Huber, Kurt
    Slagboom, Ton
    Calabro, Paolo
    Serruys, Patrick W.
    Juni, Peter
    Valgimigli, Marco
    Windecker, Stephan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (10):
  • [28] Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy
    Huang, Sheng-Wei
    Chen, Po-Wei
    Feng, Wen-Han
    Hsieh, I-Chang
    Ho, Ming-Yun
    Cheng, Chung-Wei
    Yeh, Hung-, I
    Chen, Ching-Pei
    Huang, Wei-Chun
    Fang, Ching-Chang
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    Tsai, Chin-Feng
    Su, Chun-Hung
    Li, Yi-Heng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [29] A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation in Diabetic Patients: 2-year Clinical Outcomes of DECLARE-DIABETES Trial
    Lee, Seung-Whan
    Park, Seong-Wook
    Kim, Young-Hak
    Yun, Sung-Cheol
    Park, Duk-Woo
    Lee, Cheol Whan
    Hong, Meong-Ki
    Rhee, Kyoung-Sul
    Chae, Jei Keon
    Ko, Jae-Ki
    Park, Jae-Hyeong
    Lee, Jae-Hwan
    Choi, Si Wan
    Jeong, Jin-Ok
    Seong, In-Whan
    Cho, Yoon Haeng
    Lee, Nae-Hee
    Kim, June Hong
    Chun, Kook Jin
    Kim, Hyun-Sook
    Park, Seung-Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 23I - 24I
  • [30] P2Y12 Inhibitor Monotherapy After Short-term Dual Antiplatelet Therapy in Patients Receiving Percutaneous Coronary Intervention
    Lone, Ahmad Naeem
    Khan, Safi U.
    CIRCULATION, 2020, 142
12345